RAC1 and atherosclerosis: The issue of farnesylation and geranylgeranylation of RhoA, Rac1, and CDc42 in atherosclerosis is important for the therapeutic use of the lipid-lowering agents, statins, in the prevention and reduction of atherosclerosis.